Table 2.
SAVR Demographics (Patient, Financial, and Hospital Levels) From 2012 to 2015 in Patients With Cancer Versus Patients Without Cancer
| Variables | Patients With Cancer (n=17 290) | Patients Without Cancer (n=96 115) | P Value |
|---|---|---|---|
| Patient characteristics | |||
| Age, mean±SE, y | 73.0±0.2 | 68.8±0.1 | <0.0001 |
| 50–65 y, % | 15.7 | 32.1 | <0.0001 |
| ≥65 y, % | 84.3 | 67.9 | |
| Women, % | 37.8 | 39.9 | 0.03 |
| Race, % | <0.0001 | ||
| White | 88.3 | 83.0 | |
| Black | 3.5 | 5.3 | |
| Hispanic | 3.9 | 6.6 | |
| Asian or Pacific Islander | 0.9 | 1.5 | |
| Native American | 0.2 | 0.4 | |
| Other | 3.2 | 3.2 | |
| Income quartiles | <0.0001 | ||
| 0–25 | 17.7 | 21.9 | |
| 26–50 | 24.6 | 25.5 | |
| 51–75 | 27.2 | 26.2 | |
| 76–100 | 30.5 | 26.3 | |
| Payment source, % | <0.0001 | ||
| Medicare | 78.7 | 64.2 | |
| Medicaid | 1.7 | 3.8 | |
| Private | 17.6 | 28.3 | |
| Self‐pay | 0.6 | 1.5 | |
| No charge | 0.1 | 0.2 | |
| Others | 1.3 | 1.9 | |
| Comorbidities, % | |||
| Traditional cardiovascular | |||
| Cardiomyopathy | 7.1 | 8.6 | 0.003 |
| Known coronary artery disease | 41.9 | 38.1 | <0.0001 |
| Prior myocardial infarction | 4.9 | 5.3 | 0.35 |
| Prior percutaneous coronary intervention | 9.1 | 7.3 | 0.0003 |
| Prior coronary bypass grafting | 6.1 | 5.5 | 0.15 |
| Carotid disease | 4.7 | 4.1 | 0.12 |
| Peripheral vascular disease | 18.8 | 19.7 | 0.21 |
| Prior TIA/stroke | 9.2 | 7.6 | 0.002 |
| Atrial fibrillation | 51.7 | 45.6 | <0.0001 |
| Hypertension | 80.0 | 77.4 | 0.0007 |
| Diabetes mellitus | 42.7 | 43.4 | 0.47 |
| Obesity | 19.9 | 23.4 | <0.0001 |
| Dyslipidemia | 64.8 | 61.2 | <0.0001 |
| Nontraditional | |||
| Weight loss | 3.7 | 3.7 | 0.99 |
| Anemia | 19.1 | 17.5 | 0.04 |
| Arthritis and collagen vascular disease | 3.5 | 3.4 | 0.63 |
| Chronic liver disease | 1.6 | 1.8 | 0.47 |
| Chronic renal disease | 18.0 | 14.6 | <0.0001 |
| Chronic lung disease | 22.6 | 21.3 | 0.08 |
| Hypothyroidism | 16.7 | 13.5 | <0.0001 |
| Neurologic | 6.1 | 6.0 | 0.94 |
| Psychiatric | 10.3 | 10.2 | 0.75 |
| Fluid/electrolyte disorder | 33.1 | 33.8 | 0.42 |
| Coagulation disorder | 35.2 | 31.7 | <0.0001 |
| Substance abuse | 2.6 | 3.3 | 0.02 |
| Smoker | 37.9 | 32.9 | <0.0001 |
| Total Elixhauser comorbidities | <0.0001 | ||
| 0 | 2.7 | 3.6 | |
| 1 | 10.9 | 13.7 | |
| 2 | 21.6 | 22.0 | |
| ≥3 | 64.8 | 60.7 | |
| Elixhauser readmission score, mean±SE | 16.2±0.3 | 13.7±0.3 | <0.0001 |
| Elixhauser mortality score, mean±SE | 8.5±0.2 | 7.1±0.1 | <0.0001 |
| Teaching hospital, % | 76.4 | 75.1 | 0.10 |
| Bed size, % | 0.10 | ||
| Small | 6.7 | 7.4 | |
| Medium | 20.2 | 21.4 | |
| Large | 73.0 | 71.2 | |
| Region, % | <0.0001 | ||
| Northeast | 24.3 | 22.2 | |
| Midwest | 24.8 | 24.2 | |
| South | 29.1 | 33.3 | |
| West | 21.8 | 20.3 | |
| Hospital in urban location, % | 98.0 | 97.6 | 0.09 |
| Weekend admission, % | 4.2 | 4.4 | 0.44 |
| Elective admission, % | 81.7 | 78.3 | <0.0001 |
SAVR indicates surgical aortic valve replacement; TIA, transient ischemic attack.